PHASE I STUDY OF INTRAVESICAL VACCINIA VIRUS AS A VECTOR FOR GENE THERAPY OF BLADDER CANCER-Reference-Cited by-同舟云学术

PHASE I STUDY OF INTRAVESICAL VACCINIA VIRUS AS A VECTOR FOR GENE THERAPY OF BLADDER CANCER

Published:2001-10 Issue:4 Volume:166 Page:1291-1295
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

GOMELLA LEONARD G.¹,MASTRANGELO MICHAEL J.¹,McCUE PETER A.¹,MAGUIRE HENRY C.¹,MULHOLLAND S. GRANT¹,LATTIME EDMUND C.¹

Affiliation:

1. From the Departments of Urology, Pathology and Medicine (Division of Medical Oncology), Jefferson Medical College and the Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference28 articles.

1. Principles of intravesical chemotherapy and immunotherapy;Sarosdy;Urol Clin North Am,1992

2. Intravesical therapy for bladder cancer;Kamat;Urology,2000

3. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study;Lamm;J Urol,2000

4. Analysis of early failures after intravesical instillation therapy with bacille Calmette-Guerin for carcinoma in situ of the bladder;Merz;Br J Urol,1995

5. Risks and benefits of repeated courses of intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer;Catalona;J Urol,1987

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine approaches to treat urothelial cancer;Human Vaccines & Immunotherapeutics;2024-07-23

2. Evaluating a combination treatment of NK cells and reovirus against bladder cancer cells using an in vitro assay to simulate intravesical therapy;Scientific Reports;2024-03-28

3. Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors;Molecular Therapy - Oncolytics;2023-09

4. Correlative analysis from a phase I clinical trial of intrapleural administration of oncolytic vaccinia virus (Olvi-vec) in patients with malignant pleural mesothelioma;Frontiers in Immunology;2023-02-16

5. Vaccines and Immunomodulators;Holland‐Frei Cancer Medicine;2022-10-21